<DOC>
	<DOCNO>NCT00978055</DOCNO>
	<brief_summary>The objective study investigate bioequivalence Mylan 's liothyronine sodium 50 mcg tablet King 's Cytomel® 50 mcg tablet follow single , oral 100 mcg ( 2 x 50 mcg ) dose administration fasting condition .</brief_summary>
	<brief_title>Fasting Study Liothyronine Sodium Tablets ( 50 Mcg ) Cytomel® Tablets ( 50 Mcg )</brief_title>
	<detailed_description />
	<criteria>healthy male and/or nonpregnant , nonlactating female , 18 year older able swallow medication institutionalized subject history significant disease use prescription OTC medication within 14 day prior start study receive investigational product within 30 day prior start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>